Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Ferrari

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Iscience|April 17, 2023
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concernMelissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, et al.
Travel Medicine and Infectious Disease|March 31, 2024
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, ItalyAntonio Piralla, Davide Mileto, Alberto Rizzo, et al.
Iscience|January 12, 2022
Immunity to SARS-CoV-2 up to 15 months after infectionHarold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
The Journal of Experimental Medicine|June 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patientsAdrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Iscience|April 17, 2023
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concernMelissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, et al.
Travel Medicine and Infectious Disease|March 31, 2024
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, ItalyAntonio Piralla, Davide Mileto, Alberto Rizzo, et al.
Iscience|January 12, 2022
Immunity to SARS-CoV-2 up to 15 months after infectionHarold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
The Journal of Experimental Medicine|June 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patientsAdrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
Pageof 10